Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer
Ian M. McElree, Joanna Orzeł, Reid Stubbee, Ryan L. Steinberg, Sarah L. Mott, Michael A. O’Donnell, Vignesh T. Packiam
Topics & Concepts
MedicineDocetaxelGemcitabineBladder cancerMitomycin CInternal medicineUrologyAdjuvantRetrospective cohort studyCohortAdverse effectOncologySurgeryCancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Bladder and Prostate Research